NCT03486912 A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis Status COMPLETED Phase PHASE2
NCT03486899 A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis Status COMPLETED Phase PHASE2
NCT03472586 Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver Status COMPLETED Phase PHASE2
NCT03470922 A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT03466814 Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown Origin Status COMPLETED Phase N/A
NCT03465592 Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma Status RECRUITING Phase PHASE1/PHASE2
NCT03461952 Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe) Status TERMINATED Phase PHASE2
NCT03459222 An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread Status COMPLETED Phase PHASE1/PHASE2
NCT03457792 A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT03457142 Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy Status TERMINATED Phase PHASE2
NCT03456648 Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study Status COMPLETED Phase PHASE2
NCT03455452 Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03451331 Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer Status COMPLETED Phase PHASE2
NCT03448497 Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom Status COMPLETED Phase N/A
NCT03447990 v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491 Status COMPLETED Phase PHASE1/PHASE2
NCT03446040 An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread Status TERMINATED Phase PHASE1/PHASE2
NCT03445533 A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma Status TERMINATED Phase PHASE3
NCT03445208 A Study of Experimental Medication BMS-986036 Given to Healthy Participants Status COMPLETED Phase PHASE1